This inventor holds 1 USPTO granted patent. Top assignee: The Ohio State University. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Motoyashi Saji: Innovator in Anticancer Research
Introduction
Motoyashi Saji is a notable inventor based in Dublin, OH (US). He has made significant contributions to the field of cancer research through his innovative work on p21-activated kinase inhibitors. His research focuses on developing compounds that can effectively inhibit these kinases, which play a crucial role in cancer progression.
Latest Patents
Motoyashi Saji holds a patent for "Anticancer P21-activated kinase inhibitors." This patent describes compounds according to a specific formula, where Ar is a fused aryl group, and R is selected from alkyl and aryl amides, CF, and CHOH. The compounds are effective for inhibiting p21-activated kinases and can be utilized for the prevention and treatment of cancer. He has 1 patent to his name.
Career Highlights
Motoyashi Saji is associated with the Ohio State Innovation Foundation, where he continues to advance his research in cancer therapeutics. His work is pivotal in the ongoing fight against cancer, contributing to the development of new treatment options.
Collaborations
He has collaborated with esteemed colleagues such as Ching-Shih Chen and Matthew David Ringel, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Motoyashi Saji's innovative work in anticancer research exemplifies the importance of scientific inquiry in developing effective treatments. His contributions are vital in the ongoing battle against cancer, showcasing the potential of targeted therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile